Global Neoantigen Targeted Therapy Market 2023 by Company, Regions, Type and Application, Forecast to 2029

According to our Researcher latest study, the global Neoantigen Targeted Therapy market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

Rising prevalence of malignancies and colon cancer, patient preference for targeted therapy, and increased risk of ovarian cancer among women are key factors for increasing market revenue.

Neoantigen therapy is mainly through high-throughput gene sequencing and data analysis to discover individualized numerous somatic mutations in the patient's tumor, screen out mutations that may become neoantigens as targets, and load them on antigen-producing cells (APCs), thereby It has the effect of activating T cells to recognize a variety of new antigens, and then kill tumors.

This report is a detailed and comprehensive analysis for global Neoantigen Targeted Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Neoantigen Targeted Therapy market size and forecasts, in consumption value ($ Million), 2018-2029

Global Neoantigen Targeted Therapy market size and forecasts by region and country, in consumption value ($ Million), 2018-2029

Global Neoantigen Targeted Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029

Global Neoantigen Targeted Therapy market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Neoantigen Targeted Therapy

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Neoantigen Targeted Therapy market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include BioNTech SE, Gritstone Bio, Genocea Biosciences, Moderna and Agenus, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation

Neoantigen Targeted Therapy market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

Off-the-shelf Neoantigen

Personalized Neoantigen

Market segment by Application

Colorectal Cancer

Renal Cell Carcinoma

Non-Small Cell Lung cancer

Bone Cancer

Gynecological Cancer

Others

Market segment by players, this report covers

BioNTech SE

Gritstone Bio

Genocea Biosciences

Moderna

Agenus

Immatics

Advaxis

Precision Biologics

Gilead Sciences

Cellular Biomedicine Group

Achilles Therapeutics

Merck and Co

Beijing Kati Medical Technology

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Argentina and Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Neoantigen Targeted Therapy product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Neoantigen Targeted Therapy, with revenue, gross margin and global market share of Neoantigen Targeted Therapy from 2018 to 2023.

Chapter 3, the Neoantigen Targeted Therapy competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Neoantigen Targeted Therapy market forecast, by regions, type and application, with consumption value, from 2024 to 2029.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War

Chapter 12, the key raw materials and key suppliers, and industry chain of Neoantigen Targeted Therapy.

Chapter 13, to describe Neoantigen Targeted Therapy research findings and conclusion.